Greenway Greenhouse Cannabis Corp. (GWAY) AI Stock Analysis

1 Followers

Greenway Greenhouse Cannabis Corp.

(CNQX:GWAY)

Select Model

Rating:41Neutral

Price Target:CAD 0.07▼(-16.25% Downside)

Action:reiterated

Date:10/27/26

The score is primarily held back by weak financial performance: thin gross margin, sizable net losses, a return to negative operating/free cash flow, and elevated leverage with declining equity. Technicals also remain bearish with the stock below all major moving averages and negative MACD, only mildly offset by near-oversold RSI/Stoch readings. Valuation is constrained by losses (negative P/E) and no dividend support.

Positive Factors

Revenue GrowthTTM revenue growth of 8.2% shows the company is still expanding sales despite broader profitability pressure. Continued top-line progress can support better operating leverage and provide a base for improving cultivation economics if pricing, yields, and product mix stabilize.

Negative Factors

Low Margins and Deep LossesVery low gross margin and deep net losses show that revenue is not currently converting into sustainable earnings. This limits internal funding capacity, reduces resilience to changes in wholesale pricing or cultivation costs, and makes durable profitability dependent on substantial operating improvement.

Greenway Greenhouse Cannabis Corp. (GWAY) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 10.69M
Dividend Yield: ―
Average Volume (3M): 9,668
Price to Earnings (P/E): -3.6
Beta (1Y): 0.72
Revenue Growth: -1.41%
EPS Growth: -78.91%
Country: Canada
Employees: 10
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Greenway Greenhouse Cannabis Corp. Business Overview & Revenue Model

Company Description

Greenway Greenhouse Cannabis Corporation specializes in the cultivation, processing, and distribution of dried cannabis flower and kief. This company, established in 2018, operates out of Kingsville, Canada, and is a subsidiary of Sunrite Greenhouses...

How the Company Makes Money

Greenway Greenhouse Cannabis Corp. primarily makes money by selling cannabis produced at its cultivation operations into the Canadian regulated supply chain, with revenues largely tied to B2B/wholesale transactions rather than direct-to-consumer reta...

Greenway Greenhouse Cannabis Corp. Financial Statement Overview

Summary

Financials remain weak despite modest TTM revenue growth (+8.2%). Profitability is poor (gross margin ~7.7%), operating results are loss-making, and net losses are deep (~-38% of revenue). Cash flow has deteriorated back to negative (TTM operating cash flow ~-1.0M; free cash flow ~-1.1M). Balance-sheet risk is elevated with high leverage (debt ~2.17x equity) and declining equity (~15.0M in 2023 to ~7.1M TTM).

Income Statement

32Negative

Balance Sheet

38Negative

Cash Flow

30Negative

Financial statement breakdown
Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Mar 2022
Income Statement
Total Revenue	8.06M	7.45M	8.95M	5.23M	5.62M	1.98M
Gross Profit	616.88K	188.40K	1.68M	-335.38K	741.99K	844.02K
EBITDA	70.27K	446.31K	972.53K	-2.21M	-576.34K	-1.36M
Net Income	-3.06M	-2.56M	-2.06M	-4.72M	-2.61M	-2.92M
Balance Sheet
Total Assets	30.42M	31.01M	32.26M	33.09M	35.30M	35.63M
Cash, Cash Equivalents and Short-Term Investments	1.13M	1.14M	3.14M	1.53M	3.64M	7.48M
Total Debt	15.53M	15.58M	15.79M	16.02M	13.96M	16.67M
Total Liabilities	23.28M	23.26M	22.21M	21.17M	20.36M	18.77M
Stockholders Equity	7.14M	7.75M	10.05M	11.92M	14.95M	16.86M
Cash Flow
Free Cash Flow	-1.06M	-2.01M	1.61M	-4.96M	-4.38M	-4.10M
Operating Cash Flow	-971.95K	-1.87M	1.81M	-2.05M	2.23M	-1.97M
Investing Cash Flow	-86.85K	-132.20K	-194.37K	-2.92M	428.31K	-2.12M
Financing Cash Flow	0	0	0	2.85M	-6.49M	8.12M

Greenway Greenhouse Cannabis Corp. Technical Analysis

Technical Analysis SentimentNegative

Last Price0.08

Price Trends

50DMA0.08Negative

100DMA0.10Negative

200DMA0.13Negative

Market Momentum

MACD-0.00Negative

RSI44.70Neutral

STOCH75.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GWAY, the sentiment is Negative. The current price of 0.08 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.08, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 44.70 is Neutral, neither overbought nor oversold. The STOCH value of 75.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GWAY.

Greenway Greenhouse Cannabis Corp. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:GWAY against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:LABS	57Neutral	CAD 27.77M	-10.00	-7.66%	―	-9.31%	66.84%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:ROMJ	44Neutral	CAD 28.72M	-17.28	-4.00%	―	16.66%	-1007.41%
TSE:AVCN	42Neutral	CAD 13.44M	-4.54	-65.40%	―	-3.32%	-34.15%
TSE:GWAY	41Neutral	CAD 10.69M	-3.62	-35.33%	―	-1.41%	-78.91%
TSE:AYR.A	40Neutral	CAD 18.10M	-0.03	-74.75%	―	―	―
TSE:PCLO	23Underperform	CAD 8.41M	-2.41	28.59%	―	0.90%	57.73%

* Healthcare Sector Average

Performance Comparison

TSE:GWAY and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:GWAY	Greenway Greenhouse Cannabis Corp.	0.08	-0.10	-55.56%
TSE:AYR.A	Ayr Wellness Inc.	0.15	0.00	0.00%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-7.14%
TSE:PCLO	Pharmacielo	0.04	0.00	0.00%
TSE:ROMJ	Rubicon Organics	0.42	-0.07	-14.14%
TSE:AVCN	Avicanna Inc	0.10	-0.13	-55.56%

Greenway Greenhouse Cannabis Corp. Corporate Events

Business Operations and StrategyFinancial Disclosures

Greenway boosts revenue and volumes as it refines premium cannabis portfolio

Positive

Aug 31, 2026

Greenway Greenhouse Cannabis Corp. reported first‑quarter fiscal 2027 net revenue of $2.23 million, up 38 per cent year over year, as grams sold reached a record 2.33 million. Despite a net loss of $659,893, the company delivered positive adjusted EB...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 27, 2026

Greenway Greenhouse Cannabis Corp. AI Stock Analysis